Fludarabine Phosphate 45963-0609-55
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- January 5, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA078610
Need to source Fludarabine Phosphate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fludarabine Phosphate | 50 mg/2mL |
Drug Class
Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Selected Package
45963-0609-55Selected1 VIAL, GLASS in 1 CARTON (45963-609-55) / 2 mL in 1 VIAL, GLASS